0001127602-18-011413.txt : 20180313 0001127602-18-011413.hdr.sgml : 20180313 20180313172035 ACCESSION NUMBER: 0001127602-18-011413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180312 FILED AS OF DATE: 20180313 DATE AS OF CHANGE: 20180313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEISS ROBERT S CENTRAL INDEX KEY: 0001181959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 18687413 MAIL ADDRESS: STREET 1: 6140 STANERIDGE MALL RES #590 CITY: PLEASSANTON STATE: CA ZIP: 94503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-03-12 0000711404 COOPER COMPANIES INC COO 0001181959 WEISS ROBERT S 6140 STONERIDGE MALL ROAD SUITE 590 PLEASANTON CA 94588 1 1 President & CEO Common Stock 2018-03-12 4 M 0 36769 95.74 A 135936 D Common Stock 2018-03-12 4 S 0 8431 241.57 D 127505 D Common Stock 2018-03-12 4 S 0 27209 242.57 D 100296 D Common Stock 2018-03-12 4 S 0 1129 242.99 D 99167 D Common Stock 46453 I Robert S. Weiss and Marilyn A. Weiss, Trustees of the Robert and Marilyn Weiss Trust dated 5/17/06 Employee Stock Option (Right to Buy) 95.74 2018-03-12 4 M 0 36769 0 D 2022-12-11 Common Stock 36769 0 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.97 to $241.965. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. The sales price represents a weighted average of sales prices ranging between $241.97 and $242.965. The sales price represents a weighted average of sales prices ranging between $242.97 and $243.02. 12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17. /s/ Robert S. Weiss 2018-03-13